Literature DB >> 10778899

Endoscopic revision surgery for recurrent epiphora occurring after external dacryocystorhinostomy.

A El-Guindy1, A Dorgham, M Ghoraba.   

Abstract

Recurrent epiphora after external dacryocystorhinostomy (DCR) can be a frustrating experience for both the patient and the physician. We present the results of a retrospective study of 18 patients with epiphora recurring after external DCR who were operated upon to recreate lacrimal drainage through an endoscopic endonasal approach. The procedure was successful in 83.3% of cases, with no major complications. The results are comparable to those of an external approach, but the cosmetic advantages are clear. It is a 1-stage procedure that permits correction of associated intranasal disease that may be a causative factor in the recurrence of lacrimal obstruction. The endoscopic endonasal approach is a relatively safe and reliable option in the management of recurrent epiphora.

Entities:  

Mesh:

Year:  2000        PMID: 10778899     DOI: 10.1177/000348940010900414

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  14 in total

1.  A comparison of endonasal with external dacryocystorhinostomy in revision cases.

Authors:  Arzu Yasemin Korkut; Aysenur Meric Teker; Mustafa Ozsutcu; Omer Askiner; Orhan Gedikli
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-07-21       Impact factor: 2.503

2.  Magnetic resonance imaging in the pre-operative evaluation of obstructive epiphora: true-FISP and VIBE vs gadolinium.

Authors:  Francesco Somma; Vincenzo d'Agostino; Fabio Tortora; Nicola Serra; Gerardo Sorrentino; Valeria Piscitelli; Andrea Somma; Mario Gamerra
Journal:  Radiol Med       Date:  2016-11-05       Impact factor: 3.469

3.  Our experience with transcanalicular laser-assisted endoscopic dacryocystorhinostomy (TCLADCR) in patients of chronic dacryocystitis with deviated nasal septum.

Authors:  Ruchi Goel; Smriti Nagpal; Sushil Kumar; Saurabh Kamal; Sonal Dangda; Sonam Angmo Bodh
Journal:  Int Ophthalmol       Date:  2015-02-22       Impact factor: 2.031

4.  Outcomes of revision external dacryocystorhinostomy and nasal intubation by bicanalicular silicone tubing under endonasal endoscopic guidance.

Authors:  Seyhmus Ari; Abdullah Kürşat Cingü; Alparslan Sahin; Ramazan Gün; Vefa Kiniş; Ihsan Caça
Journal:  Int J Ophthalmol       Date:  2012-04-18       Impact factor: 1.779

5.  Management of traumatic dacryocystitis and failed dacryocystorhinostomy using silicone lacrimal intubation set.

Authors:  Syed Ali Raza Rizvi; Satish C Sharma; Satyaswarup Tripathy; Surabhi Sharma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-17

6.  Management of chronic dacryocystitis cases after failed external dacryocystorhinostomy using endoscopic technique with a novel lacrimal ostium stent.

Authors:  Bo Yu; Yun-Hai Tu; Guang-Ming Zhou; Jie-Liang Shi; En-De Wu; Wen-Can Wu
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

7.  Endonasal DCR with Silicon Tube Stents: A Better Management for Acute Lacrimal Abscesses.

Authors:  Sudhir M Naik; Mohan K Appaji; S Ravishankara; Annapurna S Mushannavar; Sarika S Naik
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-02-16

8.  External Dacryocystorhinostomy; Success Rate and Causes of Failure in Endoscopic and Pathologic Evaluations.

Authors:  Hassan Ghasemi; Sajedeh Asghari Asl; Mohammad Ebrahim Yarmohammadi; Farhad Jafari; Pupak Izadi
Journal:  Iran J Pathol       Date:  2017-07-01

9.  [Endoscopic nasal dacryocystorhinostomy: results and advantages over the external approach].

Authors:  Daniel Salgado Küpper; Ricardo Cassiano Demarco; Renato Resende; Wilma Terezinha Anselmo-Lima; Fabiana Cardoso P Valera; Iracema Moribe
Journal:  Braz J Otorhinolaryngol       Date:  2005-12-14

10.  Etiologic analysis of 100 anatomically failed dacryocystorhinostomies.

Authors:  Tarjani Vivek Dave; Faraz Ali Mohammed; Mohammad Javed Ali; Milind N Naik
Journal:  Clin Ophthalmol       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.